Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC.

D Y Hou1, A W Hamburger, J L Beach

  • 1Division of Developmental Therapeutics, University of Maryland Cancer Center, Baltimore 21201.

Cancer Investigation
|January 1, 1989
PubMed
Summary

The novel [111In]bleomycin complex ([111In]BLMC) demonstrated superior cytotoxicity against human small cell lung cancer cells compared to bleomycin alone. This enhanced efficacy suggests [111In]BLMC as a promising agent for lung cancer therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cardioprotective Effects of Late-Phase Remote Preconditioning of Trauma Depends on Neurogenic Pathways and the Activation of PKC and NF-κB (But Not iNOS) in Mice.

Journal of cardiovascular pharmacology and therapeutics·2015
Same author

Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.

British journal of cancer·2013
Same author

Genetics and molecular mapping of genes for high-temperature resistance to stripe rust in wheat cultivar Xiaoyan 54.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2011
Same author

Detection of ErbB Receptor Family Tyrosyl Phosphorylation in Ovarian Carcinoma Cells.

Methods in molecular medicine·2011
Same author

Induction of new ADAM related proteins from treated human Chang-liver cells.

Molekuliarnaia biologiia·2010
Same author

Fluoride removal from brackish groundwater by direct contact membrane distillation.

Water science and technology : a journal of the International Association on Water Pollution Research·2010

Area of Science:

  • Oncology
  • Radiopharmaceuticals
  • Cancer Therapeutics

Background:

  • Bleomycin (BLM) is a chemotherapy agent used for various cancers.
  • Investigating novel drug delivery systems can enhance therapeutic efficacy.
  • Radioisotopes combined with cytotoxic drugs offer potential for targeted cancer treatment.

Purpose of the Study:

  • To evaluate the cytotoxic effects of a [111In]bleomycin complex ([111In]BLMC) on human small cell lung cancer (SCLC) cell lines.
  • To compare the efficacy of [111In]BLMC with bleomycin (BLM) and its components alone.
  • To assess the potential of [111In]BLMC as a therapeutic agent for lung cancer.

Main Methods:

  • Human SCLC cell lines were exposed to various agents: 0.9% NaCl, [111In]Cl3, BLM, [111In]BLMC, nonradioactive InCl3, or In-BLMC.

Related Experiment Videos

  • Cells were incubated for 60 minutes, followed by plating in soft agarose.
  • Colony formation was assessed to determine cell survival and cytotoxicity.

    • Main Results:

    • [111In]BLMC exhibited significantly higher cytotoxicity than BLM across five SCLC cell lines, with a 1.6-5.3 fold increase.
    • For N417 cells, [111In]BLMC reduced survival to 28.4% (40 microCi/15 micrograms BLM/ml) and 1.9% (200 microCi/25 micrograms BLM/ml), compared to 54.3% and 10.0% for BLM respectively.
    • [111In]Cl3 and nonradioactive InCl3 did not inhibit colony formation, indicating the complex's specific activity.

    Conclusions:

    • The [111In]bleomycin complex ([111In]BLMC) demonstrates enhanced cytotoxic activity against human small cell lung cancer cells.
    • The results suggest that [111In]BLMC is more effective than conventional bleomycin therapy.
    • [111In]BLMC holds potential as a novel therapeutic option for specific lung cancer patient populations.